The effects of converting to Dysport from other botulinum toxin type A formulations for treating cervical dystonia patients
Objective: To investigate whether Dysport increases waning time compared to other botulinum toxin type A (BoNT-A) formulations for cervical dystonia (CD) therapy. Background: BoNT-A injections…Dysphagia and its relationship to medication intake in Parkinson’s disease
Objective: This study attempted to obtain a comprehensive picture of medication intake dysphagia in Parkinson’s disease (PD). Specific investigations included 1) An objective, graduated and…DystoniaBoTXNet: A Deep Learning Platform for Predictive Outcome of Botulinum Toxin Treatment in Isolated Dystonia
Objective: To develop and validate an objective measure of the botulinum toxin treatment outcome in isolated dystonia. Background: Dystonia is characterized by abnormal, often painful,…Duration of continuous “Good On” intervals and number of motor fluctuations after treatment with IPX203 vs immediate-release carbidopa-levodopa in Parkinson’s disease patients with motor fluctuations.
Objective: To compare the duration of continuous “On” without troublesome dyskinesia (“Good On”) intervals and number of motor fluctuations per day in Parkinson’s disease (PD)…Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)
Objective: To describe the new category of nociplastic pain (NP). We defined Parkinson's disease (PD)-related pains and allocated them to a mechanistic category by using the…The Parkinson’s Incidence Cohorts Collaboration (PICC): an international collaboration of incident PD cohorts
Objective: To (i) identify all incidence cohorts of Parkinson’s disease (PD) with long-term follow up and (ii) pool data from these cohorts to study PD…Botulinum Toxin A in the Management of peripheral mononeuropathy: post herpetic neuralgia and trigeminal neuralgia
Objective: The purpose of this study is determinate the efficacy and safety of botulin toxin A in the treatment of refractory post herpetic neuralgia and…Systematic Review and Network Meta-Analysis of COMT and MAO-B Inhibitors in Parkinson’s Patients with Motor Fluctuations
Objective: This study compared the effects of catechol-O-methyl transferase (COMT) inhibitors and monoamine oxidase‑B (MAO-B) inhibitors on mean change from baseline to end-of-study in OFF-time…An Ecologic Study of Aqueous Lead Exposure and Parkinson’s Disease
Objective: Examine the potential role of lead in water as a risk factor for PD. Background: Studying disease rates in different locations is an established…TWO-YEAR LONGITUDINAL FOLLOW-UP OF VISUAL ILLUSIONS AND HALLUCINATIONS IN PARKINSON’S DISEASE
Objective: To determine whether visual illusions (VI) evolve towards visual hallucinations (VH) along the time in Parkinson’s disease (PD), and whether ophthalmological treatment may have…
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 153
- Next Page »